On October 9, ASYMCHEM fell 3.37% in regular trading, trading at HK$157.3 per share, with turnover of HK$2.95 million. The decline comes amid continued institutional selling of its H-shares and broader post-holiday risk-aversion sentiment.

Recent regulatory filings show JPMorgan Chase sold shares off-market at an average price of HK$159.1287 on September 23, reducing its long position to 8.8%, while Schroders PLC cut its stake on September 24 at around HK$150.23 per share. The consecutive reductions have weighed on market confidence despite solid fundamentals, including an order backlog of US$1.673 billion, up 53.77% year-over-year, and successful completion of an FDA pre-approval inspection for its chemical macromolecule facility.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)